✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-09

GLP-1 Medications and Insulin: Can They Be Used Together?

Combining a GLP-1 with insulin is possible for some patients, but it raises hypoglycemia risk and always calls for physician-managed dosing.

Yes, GLP-1 medications and insulin can sometimes be used together, but only under close physician supervision. Combining the two raises the risk of low blood sugar, called hypoglycemia, so insulin doses often need careful adjustment. If you take insulin, never start, stop, or change either medication on your own. At New Hope Weight Loss, Dr. Anjmun Sharma, MD, reviews your full medication list before prescribing.

A physician on a telehealth video call

Why GLP-1s and Insulin Need Extra Care Together

GLP-1 medications such as semaglutide and tirzepatide lower blood sugar in a glucose-dependent way, which means they mainly act when blood sugar is elevated. Used alone, they rarely cause hypoglycemia. Insulin is different. It lowers blood sugar whether levels are high or not, so adding a GLP-1 on top of an unchanged insulin dose can push glucose lower than intended.

GLP-1s also slow stomach emptying and reduce appetite. If you eat much less while injecting the same amount of insulin, blood sugar can drop further than expected. This combination works for many patients with type 2 diabetes, but it is never a do-it-yourself adjustment.

How Physician-Managed Dosing Works

When a GLP-1 is added for a patient already using insulin, physicians typically lower the insulin dose first, then adjust gradually while watching glucose readings. You may be asked to check blood sugar more often during the first weeks, and your weight loss physician should coordinate with whoever manages your diabetes care. Any dose change is the physician's decision, not something to attempt on your own.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

It also helps to know the warning signs of low blood sugar and act promptly if they appear:

Who Needs Extra Caution

Some people need closer monitoring than others before these medications are combined:

How New Hope Weight Loss Screens for Safety

Every patient starts with a $119 medical review in which Dr. Anjmun Sharma, MD, goes through your health history, current medications, and labs before deciding whether a GLP-1 is appropriate for you. If you use insulin, that conversation includes a monitoring plan and coordination with your diabetes care, whether you visit our Costa Mesa office or connect by telehealth.

The compounded semaglutide and compounded tirzepatide we prescribe are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. Brand medications such as Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved, and the same hypoglycemia precautions apply either way when insulin is part of your regimen.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Can you take a GLP-1 medication and insulin at the same time?

Often yes, but only with physician supervision. Insulin doses usually need adjustment when a GLP-1 is added, so the combination should always be managed by your doctor.

Do GLP-1 medications cause low blood sugar on their own?

Rarely. GLP-1s mainly act when blood sugar is elevated, so hypoglycemia is uncommon when they are used alone. The risk rises mainly when they are combined with insulin or sulfonylureas.

Will my insulin dose change if I start a GLP-1?

It may. Physicians often lower insulin when adding a GLP-1 and then adjust based on glucose readings. Never change your insulin dose on your own; that decision belongs to your prescribing physician.

What are the warning signs of hypoglycemia?

Common signs include shakiness, sweating, a racing heartbeat, sudden hunger, dizziness, and confusion. If you notice these while taking insulin and a GLP-1, check your blood sugar and contact your physician.

Can people with type 1 diabetes use GLP-1 medications for weight loss?

Sometimes, but it is a specialist-level decision because insulin is essential in type 1 diabetes. It requires close coordination between your endocrinologist and your weight loss physician, plus careful glucose monitoring.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.